-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Leap Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2017 to 2023.
- Leap Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 41.2M shares, a 52.7% increase year-over-year.
- Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 20.4M shares, a 80.5% increase from 2022.
- Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.3M shares, a 86.8% decline from 2021.
- Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 85.8M shares, a 44.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)